Prevalence of HER2 overexpression and amplification in cervical cancer: A systematic review and meta-analysis

The reported rates of HER2 positivity in cervical cancer (CC) range from 0% to 87%. The importance of HER2 as an actionable target in CC would depend on HER2 positivity prevalence. Our aim was to provide precise estimates of HER2 overexpression and amplification in CC, globally and by relevant subgr...

Descripción completa

Detalles Bibliográficos
Autores principales: Itkin, Boris, Garcia, Agustin, Straminsky, Samanta, Adelchanow, Eduardo Daniel, Pereyra, Matias, Haab, Gabriela Acosta, Bardach, Ariel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483403/
https://www.ncbi.nlm.nih.gov/pubmed/34591928
http://dx.doi.org/10.1371/journal.pone.0257976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483403/
https://www.ncbi.nlm.nih.gov/pubmed/34591928
http://dx.doi.org/10.1371/journal.pone.0257976

Ejemplares similares